Abstract
For over 20 years, the concept of accelerated partial breast irradiation (APBI) has
received considerable attention. Initially concentrating on the appropriateness of
APBI as an alternative treatment to whole breast radiotherapy, investigation and innovation
evolved towards dose delivery and technique appropriateness. The purpose of this article
is to review the pertinent literature that supports the role brachytherapy serves
in delivering APBI and the recognized brachytherapy techniques for dose delivery.
Publications establishing techniques utilizing multicatheter brachytherapy, single-entry
brachytherapy applicators, permanent breast seed implantation brachytherapy, noninvasive
breast brachytherapy and electronic brachytherapy are described. The use of brachytherapy
for repeat breast conservation therapy is additionally reviewed. A historical perspective
and potential direction of future investigation and innovation are presented.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to BrachytherapyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery.J Natl Cancer Inst. 2000; 92: 269-271
- Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients.J Clin Oncol. 2005; 23: 7074-7080
- Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.Int J Radiat Oncol Biol Phys. 2004; 60: 722-730
- Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.J Natl Cancer Inst. 1990; 82: 277-282
- Accelerated partial breast irradiation as a part of breast conservation therapy.J Clin Oncol. 2005; 23: 1726-1735
- Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.Cancer. 2006; 106: 991-999
- Long-term cancer outcomes from study NRG oncology/RTOG 9517: a phase 2 study of accelerated partial breast irradiation with multicatheter brachytherapy after lumpectomy for early-stage breast cancer.Int J Radiat Oncol Biol Phys. 2016; 95: 1460-1465
- Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.Int J Radiat Oncol Biol Phys. 2003; 56: 681-689
- Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer.Am J Surg. 2000; 180: 299-304
- Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial.Radiother Oncol. 2004; 71: 281-285
- Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery.Int J Radiat Oncol Biol Phys. 2011; 80: 17-24
- Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.Brachytherapy. 2008; 7: 310-315
- Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading.Neoplasma. 2005; 52: 292-296
- Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study.Radiother Oncol. 2017; 124: 208-213
- Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study.Radiother Oncol. 2010; 94: 274-279
- 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.Lancet. 2016; 387: 229-238
- GERICO-03 phase II trial of accelerated and partial breast irradiation in elderly women: feasibility, reproducibility, and impact on functional status.Brachytherapy. 2013; 12: 285-292
- Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study.Int J Radiat Oncol Biol Phys. 2021; 109: 998-1006
- Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.Brachytherapy. 2007; 6: 286-292
- Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial.Int J Radiat Oncol Biol Phys. 2012; 83: 791-800
- A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.Int J Radiat Oncol Biol Phys. 2013; 87: 1043-1050
- Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study.Int J Radiat Oncol Biol Phys. 2013; 85: 965-970
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.Lancet. 2019; 394: 2155-2164
- A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy.Breast Cancer. 2006; 13: 289-299
- Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity.Radiat Oncol. 2010; 5: 56
- A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 months.Breast Cancer. 2022; 29: 636-644
- Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis.Breast Cancer. 2020; 27: 206-212
- Accelerated partial breast irradiation using interstitial high dose rate iridium brachytherapy: early Australian experience and review of the literature.Australas Radiol. 2006; 50: 143-151
- Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.Int J Radiat Oncol Biol Phys. 2006; 64: 489-495
- Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer.Int J Radiat Oncol Biol Phys. 2001; 50: 107-111
- ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.Radiother Oncol. 2018; 128: 411-420
- GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance.Radiother Oncol. 2016; 120: 119-123
- Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.Lancet Oncol. 2017; 18: 259-268
- Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.Lancet Oncol. 2018; 19: 834-844
- Increasing global access to brachytherapy: The ABS 300 in 10 initiative and ongoing international efforts.Brachytherapy. 2022; 21: 1-3
- Brachytherapy: a critical component of primary radiation therapy for cervical cancer: from the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).Brachytherapy. 2019; 18: 123-132
NCCN Guidelines Version 4.2022.
- Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial.Ann Surg Oncol. 2013; 20: 3279-3285
- First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.Cancer. 2005; 104: 1138-1148
- Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.Am J Surg. 2007; 194: 456-462
- Association between maximal skin dose and breast brachytherapy outcome: a proposal for more rigorous dosimetric constraints.Int J Radiat Oncol Biol Phys. 2011; 81: e173-e177
- Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.Int J Radiat Oncol Biol Phys. 2014; 88: 285-291
- Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.Int J Radiat Oncol Biol Phys. 2012; 84: 323-330
- Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.Int J Radiat Oncol Biol Phys. 2014; 90: 1025-1029
- Contura multi-lumen balloon breast brachytherapy catheter: comparative dosimetric findings of a phase 4 trial.Int J Radiat Oncol Biol Phys. 2013; 86: 264-269
- Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study.Brachytherapy. 2016; 15: 780-787
- An examination of nationwide trends in accelerated partial breast irradiation - the replacement of breast brachytherapy with intraoperative radiotherapy and external beam radiation.Radiother Oncol. 2022; 166: 79-87
- Permanent breast seed implant dosimetry quality assurance.Int J Radiat Oncol Biol Phys. 2012; 83: 84-92
- Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.Int J Radiat Oncol Biol Phys. 2009; 73: 1482-1488
- Report on the clinical outcomes of permanent breast seed implant for early-stage breast cancers.Int J Radiat Oncol Biol Phys. 2015; 93: 614-621
- Permanent breast seed implant for partial breast radiotherapy after partial mastectomy for favorable breast cancer: technique, results, and applications to various seroma presentations.Brachytherapy. 2019; 18: 510-520
- A radiation badge survey for family members living with patients treated with a (103)Pd permanent breast seed implant.Int J Radiat Oncol Biol Phys. 2008; 70: 267-271
- Updated feasibility and reproducibility results of multi-institutional study of noninvasive breast tumor bed boost.Brachytherapy. 2016; 15: 804-811
- The rationale, technique, and feasibility of partial breast irradiation using noninvasive image-guided breast brachytherapy.Brachytherapy. 2014; 13: 493-501
- Phase 2 trial of accelerated partial breast irradiation (APBI) using noninvasive image guided breast brachytherapy (NIBB).Int J Radiat Oncol Biol Phys. 2020; 108: 1143-1149
- Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: feasibility and acute toxicity.Brachytherapy. 2018; 17: 825-830
- Multi-institutional registry study evaluating the feasibility and toxicity of accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy.Brachytherapy. 2021; 20: 631-637
- Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation.Am J Clin Oncol. 2010; 33: 327-335
- Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year.Am J Clin Oncol. 2013; 36: 430-435
- Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial.Onco Targets Ther. 2010; 3: 211-218
- Recurrence and survival rates for 1400 early breast tumors treated with intraoperative radiation therapy (IORT).Ann Surg Oncol. 2022; 29: 3726-3736
- The American Brachytherapy Society consensus statement for electronic brachytherapy.Brachytherapy. 2019; 18: 292-298
- Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.JAMA Oncol. 2020; 6: 75-82
- The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.Brachytherapy. 2008; 7: 22-28
- Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.Radiother Oncol. 2012; 102: 96-101
- Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.Radiother Oncol. 2013; 108: 226-231
- Salvage mastectomy versus second conservative treatment for second ipsilateral breast tumor event: a propensity score-matched cohort analysis of the GEC-ESTRO Breast Cancer Working Group Database.Int J Radiat Oncol Biol Phys. 2021; 110: 452-461
- Partial breast irradiation as second conservative treatment for local breast cancer recurrence.Int J Radiat Oncol Biol Phys. 2004; 60: 1385-1392
- GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.Breast Cancer Res Treat. 2019; 176: 149-157
- Brachytherapy: where has it gone?.J Clin Oncol. 2015; 33: 980-982
- Education and training for image-guided adaptive brachytherapy for cervix cancer-The (GEC)-ESTRO/EMBRACE perspective.Brachytherapy. 2020; 19: 827-836
- Accelerated partial breast irradiation: executive summary for the update of an ASTRO Evidence-Based Consensus Statement.Pract Radiat Oncol. 2017; 7: 73-79
- The American Brachytherapy Society consensus statement on intraoperative radiation therapy.Brachytherapy. 2019; 18: 242-257
- Same-day breast cancer surgery and TARGIT-IORT: better than selective omission of radiotherapy?.Ann Surg Oncol. 2021; 28: 2419-2420
- Intraoperative radiation therapy for breast cancer: are we there yet?.Ann Surg Oncol. 2021; 28: 20-21
- Six-year results from a Phase I/II trial for hypofractionated accelerated partial breast irradiation using a 2-day dose schedule.Am J Clin Oncol. 2018; 41: 986-991
- Dosimetric feasibility and acute toxicity in a prospective trial of ultrashort-course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device.Ann Surg Oncol. 2013; 20: 1295-1301
- Three-fraction intracavitary accelerated partial breast brachytherapy: early provider and patient-reported outcomes of a novel regimen.Int J Radiat Oncol Biol Phys. 2019; 104: 75-82
- Three-fraction accelerated partial breast irradiation (APBI) delivered with brachytherapy applicators is feasible and safe: first results from the TRIUMPH-T Trial.Int J Radiat Oncol Biol Phys. 2019; 104: 67-74
- Very accelerated partial breast irradiation Phase I-II multicenter trial (VAPBI): feasibility and early results.Brachytherapy. 2021; 20: 332-338
- Three-fraction TRIUMPH-T brachytherapy for delivery of APBI offers effective disease control with minimal late toxicity.Int J Radiat Oncol Biol Phys. 2021; 111: S7
- Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.Brachytherapy. 2020; 19: 679-684
- A novel form of breast intraoperative radiation therapy with CT-guided high-dose-rate brachytherapy: results of a prospective phase 1 clinical trial.Int J Radiat Oncol Biol Phys. 2016; 96: 46-54
- Quality of life and Comprehensive Geriatric Assessment (CGA) in older adults receiving Accelerated Partial Breast Irradiation (APBI) using a single fraction of Multi-Catheter Interstitial High-Dose Rate Brachytherapy (MIB). The SiFEBI phase I/II trial.J Geriatr Oncol. 2021; 12: 1085-1091
- Accelerated partial breast irradiation in the elderly: 5-year results of the single fraction elderly breast irradiation (SiFEBI) phase I/II trial.Brachytherapy. 2020; 19: 90-96
- Quality of life and comprehensive geriatric assessment (CGA) in older adults receiving Accelerated Partial Breast Irradiation (APBI) using a single fraction of Multi-Catheter Interstitial High-Dose Rate Brachytherapy (MIB). The SiFEBI phase I/II trial.J Geriatr Oncol. 2021; 12: 1085-1091
- APBI versus ultra-APBI in the elderly with low-risk breast cancer: a comparative analysis of oncological outcome and late toxicity.Int J Radiat Oncol Biol Phys. 2021; 111: 56-67
- Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.J Clin Oncol. 2013; 31: 2382-2387
- Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.Lancet Oncol. 2015; 16: 266-273
- Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.Cancer Prev Res (Phila). 2014; 7: 378-387
- A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: a randomized controlled trial.Cancer. 2022; 128: 3541-3551
- Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.BMC Health Serv Res. 2022; 22: 1081
- Women with breast cancer's perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study.Support Care Cancer. 2022; 30: 4759-4768
- Randomized controlled pilot trial of a low-touch remotely-delivered values intervention to promote adherence to adjuvant endocrine therapy among breast cancer survivors.Ann Behav Med. 2022; 56: 856-871
- Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.Am J Surg. 2004; 1: 355-364
- RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis.Brachytherapy. 2014; 13: 17-22
- Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.Int J Radiat Oncol Biol Phys. 2012; 83: 512-518
- Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.Breast. 2006; 15: 319-325
- Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.Am J Surg. 2006; 192: 427-433
- Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ.Int J Radiat Oncol Biol Phys. 2013; 87: 494-498
- Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study.Radiother Oncol. 2009; 90: 23-29
Article info
Publication history
Published online: February 03, 2023
Accepted:
December 23,
2022
Received in revised form:
December 2,
2022
Received:
September 20,
2022
Publication stage
In Press Corrected ProofFootnotes
Disclosures: Dr Anderson reports no conflicts of interest. Dr Vicini reports ImpediMed (research consultant), Prelude: DCISionRT test (research advisor). Dr Wazer reports Advanced Radiation Therapy, inc. (medical advisory board). Dr. Arthur reports Advanced Radiation Therapy, inc. (medical advisory board).
Identification
Copyright
© 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
